Reprogramming astrocytes into dopaminergic neurons in vivo restores function in a Parkinson’s mouse model
nature.com/articles/s41586-020-2388-4Posted Jun 30, 2020, 6:51 PM UTC
Posted Jun 30, 2020, 6:51 PM UTC
Why do people think we can just use astrocytes like this and it's all ok? Astrocytes are like important and stuff.
I personally believe there's enough neighboring astrocytes to replenish voids created. Additionally while most astros are believed to be post-mitotic, we're not entirely sure and I hope they could proliferate in times of need.
There are orders of magnitude more astrocytes than DA neurons in the brain. I doubt repurposing a few would have any negative effects on overall astrocyte function. I imagine it's kind of like donating blood.
How many astrocytes are converted into dopaminergic neurons? Also in humans how many dopaminergic neurons could be reliably formed? What percntage of the dopaminergic neurons in substantia nigra would this make?
Is this really feasible as a treatment in humans?
Not for many years (10-20+ years atleast) and further investigations need to be done to examine a few more things, such as if the astrocytes are replenished and testing the method in older mice.
Also I really need to get my thesis going, working on this exact thing for PD and Huntington's disease.
EDIT: upon more thought, 10yrs is unrealistic. Although u/TreeFullOfBirds you asked if its feasible, and that is a good question in itself. The techniques we use to deliver DNA into these cells aren't currently used in humans. So once the methodology is shown to work, we also have to develop a technique to transfect a human brain. In our studies we use electroporation and viral transduction and I have a few ideas how to translate that to humans, but that will be another hurdle in itself.
Any progress in getting the axons of implanted cells to grow from the substantia nigra to the basal ganglia? Last I heard they just try to implant them in the target region, which could add DA tone, but not restore the degenerated circuitry
Excellent point and exactly what I'm in the process of examining. I've reprogrammed many "confused neurons" as I like to call them. Although we've also had some intriguing preliminary data with strange axon projections. Its given us hope there's some intrinsic programming guiding axon growth that is currently unknown to us. Based on our current understanding, there's no reason to believe that axons would know where to grow outside of the appropriate neurodevelopmental window, and my thesis committee is sure to voice their doubts. But that's science for you, its worth examining (and also grad school... you can't be afraid of failure).
So now I'm doing alot of tissue clearing and light-sheet microscopy to try to trace the axons we saw in the preliminary data. Easier said than done.
Thanks for giving your insight! I wish you the best in your research
Can't really weigh in on the other tech, but the in vivo transfection side of things is in human trials now.
The clinical trial results will of course depend on what's being delivered, but I know of one reagent that has passed phase 1 and has ongoing trials in phase 2-3. The reagent is safe. It's just a matter of cargo.
And those clinical trials aren't in the human brain, but both myself and several colleagues have tested it in vivo in the rodent brain and it appears both safe and effective.
Could you send me some of your papers? I’m a budding neurologist.